Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Drug Metabolism and Pharmacokinetics”

Showing 20 of 0 results

Not applicableStudy completedNCT01316549
What this trial is testing

Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation

Who this might be right for
Hematologic MalignanciesNonmalignant DiseasesImmunodeficiencies+5 more
University of California, San Francisco 67
Early research (Phase 1)Study completedNCT02845219
What this trial is testing

A Trial Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Ethinylestradiol and Levonorgestrel in an Oral Contraceptive Combination Drug in Healthy Postmenopausal Females

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 25
Early research (Phase 1)Study completedNCT00508768
What this trial is testing

Oral SCIO-469 Pharmacokinetics (Study of a Drug in the Body to Watch How the Drug is Absorbed, Distributed, Metabolized and Eliminated Over a Period of Time) in the Body of Female Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Scios, Inc. 16
Early research (Phase 1)Study completedNCT04234672
What this trial is testing

Assess Absolute Bioavailability (ABA) of TAK-831 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]TAK-831 in Male Healthy Participants

Who this might be right for
Healthy Volunteers
Neurocrine Biosciences 6
Early research (Phase 1)Study completedNCT05899738
What this trial is testing

Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT03057366
What this trial is testing

[14 C]-Pevonedistat in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors, Neoplasms, Advanced Solid
Millennium Pharmaceuticals, Inc. 8
Early research (Phase 1)Study completedNCT07065058
What this trial is testing

A Drug Drug Interaction Study to Evaluate the Effect of VCT220 on the Pharmacokinetics of Repaglinide, Rosuvastatin, and Digoxin in Healthy, Overweight, and Obese Subjects

Who this might be right for
Obesity &Amp; Overweight
Vincentage Pharma Co., Ltd 24
Large-scale testing (Phase 3)Looking for participantsNCT06328608
What this trial is testing

Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 22
Early research (Phase 1)Study completedNCT00501930
What this trial is testing

Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 12
Not applicableStudy completedNCT01913392
What this trial is testing

Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate

Who this might be right for
Obesity, MorbidTransplant; Failure, Kidney
Maisonneuve-Rosemont Hospital 15
Early research (Phase 1)Study completedNCT04059367
What this trial is testing

Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People

Who this might be right for
Healthy VolunteersOverweightObesity
Novo Nordisk A/S 45
Post-approval studies (Phase 4)Study completedNCT05029310
What this trial is testing

Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients

Who this might be right for
HyperkalemiaKidney Transplant
Oslo University Hospital 13
Early research (Phase 1)Study completedNCT05870670
What this trial is testing

A Research Study of a New Medicine NNC0519-0130 in Japanese and Non-Japanese Men

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 22
Early research (Phase 1)Looking for participantsNCT07013643
What this trial is testing

Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity

Who this might be right for
Healthy Participants
AstraZeneca 50
Early research (Phase 1)Study completedNCT01508858
What this trial is testing

Influence on the Effect of an Oral Contraceptive Drug After Administration of Liraglutide in Postmenopausal Women

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 21
Early research (Phase 1)Study completedNCT05787002
What this trial is testing

Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.

Who this might be right for
Dyslipidemia
AstraZeneca 16
Early research (Phase 1)Study completedNCT05334108
What this trial is testing

Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates for Drug Metabolism and Transport

Who this might be right for
Drug Interaction
Emalex Biosciences Inc. 56
Early research (Phase 1)Study completedNCT04142424
What this trial is testing

Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects

Who this might be right for
Metabolic DisordersNon-alcoholic Steatohepatitis
AstraZeneca 73
Early research (Phase 1)Looking for participantsNCT06672523
What this trial is testing

Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) in Participants With Advanced Solid Tumors With Homozygous Methylthioadenosine Phosphorylase Deletion

Who this might be right for
Advanced Solid Tumors With Homozygous MTAP Deletion
Bristol-Myers Squibb 8
Early research (Phase 1)Study completedNCT03811834
What this trial is testing

Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy Participants

Who this might be right for
Healthy Volunteers
Millennium Pharmaceuticals, Inc. 7
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation